Press
Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
by Quotient Therapeutics
For interview requests or speaking opportunities, get in touch with our Communications team.
Get the latest from the Quotient team